Structure-Guided Design of Novel, Potent, and Selective Macrocyclic Plasma Kallikrein Inhibitors was written by Li, Zhe;Partridge, James;Silva-Garcia, Abel;Rademacher, Peter;Betz, Andreas;Xu, Qing;Sham, Hing;Hu, Yunjin;Shan, Yuqing;Liu, Bin;Zhang, Ying;Shi, Haijuan;Xu, Qiong;Ma, Xubo;Zhang, Li. And the article was included in ACS Medicinal Chemistry Letters in 2017.Category: esters-buliding-blocks This article mentions the following:
A series of macrocyclic analogs were designed and synthesized based on the cocrystal structure of small mol. plasma kallikrein (pKal) inhibitor, I, with the pKal protease domain. This led to the discovery of a potent macrocyclic pKal inhibitor II, with an IC50 of 2 nM for one olefinic isomer and 42.3 nM for the other olefinic isomer. In the experiment, the researchers used many compounds, for example, Methyl 2-methoxy-4-methylbenzoate (cas: 81245-24-1Category: esters-buliding-blocks).
Methyl 2-methoxy-4-methylbenzoate (cas: 81245-24-1) belongs to esters. Carboxylic acid esters of low molecular weight are colourless, volatile liquids with pleasant odours, slightly soluble in water. Esters are more polar than ethers but less polar than alcohols. They participate in hydrogen bonds as hydrogen-bond acceptors, but cannot act as hydrogen-bond donors, unlike their parent alcohols. This ability to participate in hydrogen bonding confers some water-solubility.Category: esters-buliding-blocks
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics